Cleared Traditional

K244022 - 308nm UV Phototherapy System (UV-K) (FDA 510(k) Clearance)

Also includes:
308nm UV Phototherapy System (UV-X) 308nm UV Phototherapy System (UV-Y) 308nm UV Phototherapy System (UV-Z)
Mar 2025
Decision
76d
Days
Class 2
Risk

K244022 is an FDA 510(k) clearance for the 308nm UV Phototherapy System (UV-K). This device is classified as a Light, Ultraviolet, Dermatological (Class II - Special Controls, product code FTC).

Submitted by Boston Aesthetics, Inc. (Wilmington, US). The FDA issued a Cleared decision on March 13, 2025, 76 days after receiving the submission on December 27, 2024.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4630.

Submission Details

510(k) Number K244022 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2024
Decision Date March 13, 2025
Days to Decision 76 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FTC - Light, Ultraviolet, Dermatological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4630